SHINE_Streamlined_Cost_Buildup_Workbook_Amendment_1.xlsx
XLSX spreadsheet 36 KB Posted
- Solicitation number
- DARPA-PA-25-07-06
About this file
This is a Streamlined Cost Buildup Workbook template for the DARPA SHINE (Selective Harnessing of Intrinsic Neuroplasticity Engineering) program, specifically designed for proposals under Solicitation Number DARPA-PA-21-05 (referenced in the template version). The workbook is a fixed-price milestone-based budgeting tool for Other Transaction Prototype Agreements with a maximum award value of $2,000,000 per award, including both government funding and any required performer cost share.
The template structure requires proposers to build costs across an 18-month Phase 1 base period aligned with five milestone deliverables due at months 3, 6, 9, 12, and 18. Cost categories include direct labor (with hours and rates specified by labor category, excluding percent level of effort calculations), subcontractors and consultants, travel, and other direct costs—all fully burdened with indirect costs. All proposers, including universities and institutions of higher education, must provide actual labor hours and associated rates. The five milestones progress from establishing an experimental baseline and validation protocol (Month 3) through selective substrate localization (Month 6), target engagement verification (Month 9), circuit-selective neuroplasticity demonstration (Month 12), and culmination in a fully validated intervention prototype with technical documentation and end-to-end validation testing (Month 18). Payments are made solely in amounts specified in the milestone schedule, and proposers must provide detailed justification for all cost elements in Volume 2 of their price proposal.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| SHINE_Amendment_1_Summary_of_Changes.docx | DOCX document | |
| DARPA-PA-25-07-06-Amendment-01.pdf | ||
| Streamlined_Cost_Buildup_Workbook.xlsx | XLSX spreadsheet | |
| DARPA-PA-25-07-06.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Summary
| Cell Key: |
| Input |
| DARPA Solicitation Number: | Insert DO number |
| Proposal Number: | DARPA Proposal Number |
| Proposer: | Proposer's Name (Prime or Sub) |
| Prime Contractor | Prime (If Applicable) |
| Total Months | Price per Phase | |
| Phase 1 (Base) | 18 | $ - 0 |
| TOTAL PRICE PROPOSED | $ - 0 |
Budget by Month Phase 1 Base
| NOTES/INSTRUCTIONS: | ||||||||||||||||||
| 1. The milestone due dates are stipulated in the Disruption Opportunity, and Attachment 1 Task Description Document and Attachment 3 Schedule of Milestones and Payments of the DO SAMPLE OT. The milestone amounts will be automatically populated from the sums in the "Milestone [X] Total" at the bottom of this sheet. | ||||||||||||||||||
| 2. Rows can be added to reflect labor categories, subcontractors/consultants, and additional ODCs, as necessary. However, none of the fields currently in the template should be removed, to include formulas. | ||||||||||||||||||
| 3. All proposers, to include Universities/Institutions of Higher Education, must include labor hours and associated labor rates for each labor category as stipulated above. Proposers are prohibited from using percent level of effort (LOE) calculations. Proposers are reminded that the resulting awards are Fixed-Price Payable Milestone Other Transactions for Prototype Agreements (meaning, payments are made solely in the amounts found in Attachment 3 of the Agreement). | ||||||||||||||||||
| 4. Cost elements above should be fully burdened, inclusive of all applicable indirect costs. Visibility into indirect rates/costs is not required. | ||||||||||||||||||
| 5. Proposers must provide justification in Volume 2 Price Proposal and any supporting documentation as required. | ||||||||||||||||||
| 6 For PRIME submission - Subcontractor Name: If there are subcontracts, list all subcontractor names. | ||||||||||||||||||
| 7 List Principal Investigator and Key Personnel working on the project even if they receive no salary support. | ||||||||||||||||||
| 8 Subcontracts/Interorganizational Transfers: If appropriate, place Subcontractor name(s) or Interorganizational Name/Code under the Subcontractor section. | ||||||||||||||||||
| 9 Consultants: If appropriate, place Consultant name(s) under the Subcontractor section. | ||||||||||||||||||
| Cell Key: | ||||||||||||||||||
| DARPA Solicitation Number: | Insert DO number | Input | ||||||||||||||||
| Proposer: | Proposer's Name (Prime or Sub) | Calculation (DO NO EDIT) | ||||||||||||||||
| Prime Contractor | Prime (If Applicable) | No Input | ||||||||||||||||
| Milestone 1 | Milestone 2 | Milestone 3 | Milestone 4 | Milestone 5 | TOTAL PROPOSED HOURS | TOTAL PROPOSED AMOUNT | ||||||||||||
| Month 3 | ||||||||||||||||||
| (see Notes below) | Month 6 | Month 9 | Month 12 | Month 18 | ||||||||||||||
| DIRECT LABOR | ||||||||||||||||||
| (List each category separately) | HOURS | RATE | AMOUNT | HOURS | RATE | AMOUNT | HOURS | RATE | AMOUNT | HOURS | RATE | AMOUNT | HOURS | RATE | AMOUNT | |||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | ||||||||||||
| SUBTOTAL | ||||||||||||||||||
| (all direct labor costs) | - 0 | $ - 0 | - 0 | $ - 0 | - 0 | $ - 0 | - 0 | $ - 0 | - 0 | $ - 0 | - 0 | $ - 0 | ||||||
| SUBCONTRACTOR(S) & CONSULTANT(S) |
(List each separately)
| Subcontract/Interorganizational Name - #01 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| Subcontract/Interorganizational Name - #02 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| Subcontract/Interorganizational Name - #03 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| Insert line(s) for any additional Subcontractors/Interorganizational | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| SUBTOTAL | |||||||||||||
| (all subcontractor/consultant costs) | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||
| TRAVEL | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||
| OTHER DIRECT COSTS | |||||||||||||
| (List each separately) | $ - 0 | ||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||
| SUBTOTAL | |||||||||||||
| (Travel, ODCs) | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||
| TOTAL PRICE | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||
| GOVERNMENT SHARE | $ - 0 | ||||||||||||
| RECIPIENT SHARE | |||||||||||||
| (if applicable) | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
Milestone 1 Total $ - 0 Milestone 2 Total $ - 0 Milestone 3 Total $ - 0 Milestone 4 Total $ - 0 Milestone 5 Total $ - 0
DARPA-PA-21-05
Price Summary Spreadsheet
Version 2, 06/21/2022
Source Selection Information
ScheduleOfMilestonesAndPayments
| SCHEDULE OF MILESTONES AND PAYMENTS | ||||||
| Milestone # | Milestone | Exit Citeria / Deliverable | Due | |||
| Date | Payment | Funded | CLIN | |||
| SUBCLIN | ACRN | |||||
| 1 | Experimental Baseline & Validation Protocol | Finalize experimental design; identify intended neural target(s) and predefined nontarget control(s); establish quantitative validation strategy, success criteria, and comparator(s); obtain regulatory approvals as appropriate; complete baseline characterization. | Month 3 | $ - 0 | ||
| 2 | Selective Substrate Localization | Complete initial testing and deliver a quantitative dataset and analysis evaluating the localization, confinement, or activation of the intervention within predefined neural substrates relative to appropriate controls. | Month 6 | $ - 0 | ||
| 3 | Localized Target Engagement Verification | Perform target engagement assays, deliver the associated dataset analyzing and quantifying biological mechanism activation within targeted substrates using molecular, physiological, imaging, or functional biomarkers. Progress towards the final metrics must be quantifiably demonstrated with statistically significant changes found in target engagement. | Month 9 | $ - 0 | ||
| 4 | Circuit-Selective Neuroplasticity Demonstration | Complete comparative evaluations of the neuroplastic response within predefined target substrates relative to nontarget substrates and submit a Preliminary Report along with the comparative experimental dataset. | Month 12 | $ - 0 | ||
| 5 | Intervention Prototype Finalization | Deliver the fully integrated, validated intervention prototype (comprising physical hardware, biological constructs, or therapeutic delivery platforms) along with the execution of complete end-to-end intervention prototype validation testing across the full chain of evidence (selectivity, target engagement, and neuroplasticity). Delivery should include 1. The prototype assembly (or certified laboratory configuration specifications), 2. A final prototype technical data package detailing the system’s performance metrics, and 3. An end-to-end validation report demonstrating the prototype’s capability to meet program goals of either A) clinical trial readiness or B) animal testing capability. | Month 18 | $ - 0 | ||
| Total Agreement | $0.00 | $0.00 | ||||
| *Tasks and targets are aligned with OT Agreement Attachment 1 - Task Description Document | ||||||
| AUTO POPULATES FROM OTHER TABS -- DO NOT CHANGE FORMULAS OR IN THIS SPREADSHEET |
Attachment 3 - Schedule of Milestones and Payments
File details come from the government source that posted it. Updated .